Essra Ridha - Feb 8, 2023 Form 4 Insider Report for AVROBIO, Inc. (AVRO)

Role
Chief Medical Officer
Signature
/s/ Steven Avruch, Attorney in Fact for Essra Ridha
Stock symbol
AVRO
Transactions as of
Feb 8, 2023
Transactions value $
$0
Form type
4
Date filed
2/10/2023, 04:14 PM
Previous filing
Dec 9, 2022
Next filing
Feb 5, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVRO Restricted Stock Unit Award $0 +131K $0.00 131K Feb 8, 2023 Common Stock 131K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the RSU shall vest over 4 years, with 25% vesting annually on each anniversary of the Vesting Commencement Date of February 1, 2023.